Autoimmune Hemolytic Anemia (Cold Agglutinin Syndrome) in Dogs

Open table of contents

When to visit the vet?

Urgent see a veterinarian within 24 hours

?

If the condition worsens / symptoms persist, consult a veterinarian.

Download/Print

Definition

Autoimmune hemolytic anemia (Cold Agglutinin Syndrome) in dogs is a condition in which the body’s own immune system attacks and destroys red blood cells, leading to a reduced number of these cells in the blood.

The most important facts at a glance

Autoimmune Hemolytic Anemia (AIHA) in dogs is a condition in which the immune system forms antibodies against its own red blood cells, causing their destruction. A special form, Cold Agglutinin Syndrome, occurs when this destruction is intensified at low temperatures. The causes of AIHA are often unknown but can be related to other diseases or genetic predisposition. Affected dogs show symptoms such as Lethargy, pallor of mucous membranes, shortness of breath, and in severe cases, jaundice. For diagnosis, a blood count and a Coombs test are used to detect antibodies on the red blood cells. Therapy includes immunosuppressive medications such as corticosteroids and, in severe cases, blood transfusions. For Cold Agglutinin Syndrome, it is crucial to keep dogs warm to prevent relapses. The prognosis varies depending on the severity of the disease and the response to therapy. Preventive measures are difficult due to the often unknown causes, but regular veterinary examinations and avoiding stress and cold can be helpful. A healthy lifestyle with a balanced diet and exercise supports the dog’s general health.

Causes

Autoimmune Hemolytic Anemia (AIHA) is a form of anemia caused by a dysregulation of the immune system. Normally, antibodies protect the body from foreign invaders such as bacteria and viruses. In AIHA, however, antibodies are formed against the body’s own red blood cells, leading to their destruction. This destruction is called hemolysis.

In the case of Cold Agglutinin Syndrome, a subtype of AIHA, red blood cells agglutinate or clump together at low temperatures. This occurs due to the presence of cold agglutinins, a type of antibody that becomes active at lower temperatures and causes red blood cells to clump together. This clumping leads to a blockage of blood circulation and increased cell destruction.

The causes of AIHA can be diverse and are often idiopathic, meaning the exact cause is unknown. In some cases, the disease can occur secondary to other health problems such as infections, Tumors, or certain medications. Certain breeds appear to have a predisposition, including Cocker Spaniels, Poodles, and Irish Setters, which may indicate a genetic component.

Symptoms

The symptoms of autoimmune hemolytic anemia can vary but are often associated with the reduced ability of the blood to transport oxygen. Common signs include Lethargy, weakness, and reduced resilience. Since fewer red blood cells are present to transport oxygen, these symptoms can occur because the body is not getting enough oxygen.

Another common symptom is pallor of the mucous membranes, especially the gums. In dogs with severe anemia, the gums may appear almost white. Jaundice or yellowing of the skin and mucous membranes can also occur if the destruction of red blood cells leads to an accumulation of bilirubin, a breakdown product of red blood cells.

Other symptoms may include Fever, dark urine, loss of appetite, rapid heartbeat, and shortness of breath. In cases of Cold Agglutinin Syndrome, symptoms triggered by cold exposure, such as weakness or Pain in the limbs, may also occur.

Key symptoms: pallor of mucous membranes + icterus / jaundice + Increased heart rate (tachycardia) and Increased breathing rate (tachypnea) with acute performance decline.

Diagnosis

The diagnosis of AIHA usually begins with a thorough clinical examination and the dog’s medical history. An important part of the diagnosis is a blood count, which can reveal anemia and the type of anemia. In dogs with AIHA, the blood count typically shows regenerative anemia, meaning the bone marrow is trying to compensate for the loss of red blood cells by producing new ones.

A Coombs test can be performed to confirm the presence of antibodies on the red blood cells. Additionally, tests for cold agglutinins can be performed to make a specific diagnosis of Cold Agglutinin Syndrome. Further diagnostic procedures may include identifying underlying conditions that could trigger AIHA.

Imaging procedures such as X-ray or ultrasound can be useful to look for signs of infections, Tumors, or other diseases that can cause AIHA. In some cases, a bone marrow examination may also be necessary to assess the body’s ability to produce red blood cells.

Therapy

The therapy for AIHA aims to stop the destruction of red blood cells and alleviate the symptoms of anemia. The mainstay of therapy is the use of immunosuppressive medications such as corticosteroids (e.g., prednisone), which help to suppress the immune response that attacks red blood cells.

In severe cases, a blood transfusion may be necessary to rapidly increase the number of red blood cells and alleviate the symptoms of anemia. Further supportive treatments may include administering fluids to prevent dehydration or treating infections, if present.

For dogs with Cold Agglutinin Syndrome, it is important to keep them warm to prevent the activation of cold agglutinins. In some cases, it may be necessary to suppress the immune system long-term with medication to prevent a relapse.

Prognosis and follow-up care

The prognosis for dogs with AIHA is variable and depends on several factors, including the severity of the disease, the dog’s general health, and whether underlying conditions can be identified and treated. Some dogs respond well to therapy and can regain a good quality of life.

However, there are also cases where AIHA is difficult to control and the prognosis is poorer. Complications such as thromboses, caused by the increased destruction of red blood cells, can increase the risk. Dogs that have had AIHA once may be more susceptible to future episodes.

Prevention

Since the exact cause of AIHA is often unknown, there are no specific measures for the prevention of the disease. Nevertheless, some general health measures can help minimize the risk. These include regular veterinary examinations for early detection of health problems and avoiding factors that could impair the immune system.

For dogs with a known predisposition or a history of AIHA, it can be helpful to minimize stress and avoid potential triggers that could activate the immune system. Avoiding cold exposure is particularly important for dogs with Cold Agglutinin Syndrome.

Regular vaccinations and a healthy lifestyle, including a balanced diet and sufficient exercise, can also help keep the immune system in optimal condition.

Outlook on current research

In autoimmune hemolytic anemia (AIHA), the immune system is misguided and destroys red blood cells. Research pursues two goals: preventing relapses and reducing side effects of therapy. Currently, more precise tests are being developed that not only indicate whether AIHA is present but also how active the disease is. This allows for better control of medication dosages. In terms of therapies, targeted immunomodulators are coming into focus, which inhibit specific immune cells or signaling molecules without paralyzing the entire defense system. Furthermore, research is being conducted on how to reduce the risk of thrombosis, as blood clots are a significant complication. Improved blood tests and clear schemes for anticoagulation help with this. Imaging and ultrasound of the spleen and liver are intended to provide earlier warnings if the disease worsens. Additionally, research is exploring how diet, exercise, and stress management can positively influence the course. Registry data from many clinics are intended to show which combination of medications, anticoagulation, and follow-up care yields the best long-term results. The goal: stable blood values, fewer hospital stays, and as normal a life as possible for affected dogs.

Frequently asked questions (FAQs)

What is AIHA?
– A condition in which the immune system attacks its own red blood cells. -
How do I recognize it?
– Pale mucous membranes, Lethargy, rapid breathing, occasionally jaundice and dark-colored urine. -
Is it contagious?
– No. -
What triggers AIHA?
– Often unclear; sometimes infections, Tumors, medications, or vaccinations as triggers. -
How is the diagnosis made?
– Blood count, Coombs test, ultrasound, X-ray, and other lab values. -
How is it treated?
– Immunosuppressants (e.g., cortisone, second line depending on course), fluid therapy, possibly blood transfusion, anticoagulation. -
How long does the treatment take?
– Weeks to months; doses are slowly reduced. -
Are there complications?
– Blood clots, relapses, side effects of medications. -
What is the prognosis?
– Cautious, but often well controllable with early therapy. -
What can I do at home?
– Administer medications strictly, observe rest periods, manage exertion, have control appointments and blood values checked regularly.

Literature

  • Berentsen S et al. Cold agglutinin disease: current challanges and future prospects, J Blood Med. 2029;10: 93-103